pubmed-article:17139461 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0679133 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C1416655 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0238198 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C1314792 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0935989 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C1515089 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C1690540 | lld:lifeskim |
pubmed-article:17139461 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
pubmed-article:17139461 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17139461 | pubmed:dateCreated | 2007-1-25 | lld:pubmed |
pubmed-article:17139461 | pubmed:abstractText | In metastasized GISTs, resistance to imatinib after initial tumour response has been associated with observation of secondary mutations in the activation loop of KIT. The aim of the current study was to evaluate the tumour response and observance of secondary KIT mutations in a case of GIST undergoing neoadjuvant imatinib therapy. | lld:pubmed |
pubmed-article:17139461 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:language | eng | lld:pubmed |
pubmed-article:17139461 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17139461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17139461 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17139461 | pubmed:month | Feb | lld:pubmed |
pubmed-article:17139461 | pubmed:issn | 1068-9265 | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:GunawanBastia... | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:FüzesiLászlóL | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:SchultenHans-... | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:HappelNicoleN | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:KuhlgatzJensJ | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:HallerFlorian... | lld:pubmed |
pubmed-article:17139461 | pubmed:author | pubmed-author:DetkenSvenS | lld:pubmed |
pubmed-article:17139461 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17139461 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:17139461 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17139461 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17139461 | pubmed:pagination | 526-32 | lld:pubmed |
pubmed-article:17139461 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:meshHeading | pubmed-meshheading:17139461... | lld:pubmed |
pubmed-article:17139461 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17139461 | pubmed:articleTitle | Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. | lld:pubmed |
pubmed-article:17139461 | pubmed:affiliation | Department of Pathology, Georg August University, Robert-Koch-Str. 40, 37099, Göttingen, Germany. florian.haller@med.uni-goettingen.de | lld:pubmed |
pubmed-article:17139461 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17139461 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:17139461 | pubmed:publicationType | Case Reports | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17139461 | lld:pubmed |